Early Safety Findings Among Persons Aged ≥60 Years Who Received a Respiratory Syncytial Virus Vaccine — United States, May 3, 2023–April 14, 2024
by from Morbidity and Mortality Weekly Report (MMWR) on (#6N5YJ)
This report describes safety findings a year after the respiratory syncytial virus (RSV) vaccine was recommended for adults 60 and older.